MicroRNAs provide a novel pathway toward combinatorial immune checkpoint blockade

Por Mitchell, Duane A.
Publicado no Neuro Oncol (2016)

RNA-transfected dendritic cells in cancer immunotherapy

Por Mitchell, Duane A., Nair, Smita K.
Publicado em 2000

Toward effective immunotherapy for the treatment of malignant brain tumors

Por Mitchell, Duane A., Sampson, John H.
Publicado em 2009

Vaccination strategies for neuro-oncology

Por Sampson, John H., Mitchell, Duane A.
Publicado no Neuro Oncol (2015)

Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroups

Por Pham, Christina D., Mitchell, Duane A.
Publicado no Oncoimmunology (2016)

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

Por Sayour, Elias J., Mitchell, Duane A.
Publicado no J Immunol Res (2017)

Immunotherapy of malignant brain tumors

Por Mitchell, Duane A., Fecci, Peter E., Sampson, John H.
Publicado em 2008

Immunological targeting of cytomegalovirus for glioblastoma therapy

Por Nair, Smita K, Sampson, John H, Mitchell, Duane A
Publicado em 2014

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics

Por Sayour, Elias J, Sanchez-Perez, Luis, Flores, Catherine, Mitchell, Duane A
Publicado no J Immunother Cancer (2015)

Selective Modification of Antigen-Specific T Cells by RNA Electroporation

Por MITCHELL, DUANE A., KARIKARI, ISAAC, CUI, XIUYU, XIE, WEIHUA, SCHMITTLING, ROBERT, SAMPSON, JOHN H.
Publicado em 2008

A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model

Por Yang, Shicheng, Archer, Gary E., Flores, Catherine E., Mitchell, Duane A., Sampson, John H.
Publicado em 2013

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

Por Chandramohan, Vidyalakshmi, Mitchell, Duane A, Johnson, Laura A, Sampson, John H, Bigner, Darell D
Publicado em 2013

Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma

Por Sampson, John H., Archer, Gary E., Mitchell, Duane A., Heimberger, Amy B., Bigner, Darell D.
Publicado em 2008

IT-35 cGMP MANUFACTURING OF EX VIVO EXPANDED TUMOR-SPECIFIC T CELLS AND AMPLIFIED TUMOR RNA-PULSED DC VACCINES TARGETING GLIOBLASTOMA AND MEDULLOBLASTOMA

Por Yegorov, Oleg, Dechkovskaia, Anjelika, Drake, Jeffery, Cleaver, Brian D., Clement, Nathalie, Huang, Jianping, Mitchell, Duane A.
Publicado em 2014

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

Por Mitchell, Duane A., Xie, Weihua, Schmittling, Robert, Learn, Chris, Friedman, Allan, McLendon, Roger E., Sampson, John H.
Publicado em 2008

An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma

Por Gedeon, Patrick C, Choi, Bryan D, Hodges, Tiffany R, Mitchell, Duane A, Bigner, Darell D, Sampson, John H
Publicado em 2013

Proteomic and immunologic analyses of brain tumor exosomes

Por Graner, Michael W., Alzate, Oscar, Dechkovskaia, Angelika M., Keene, Jack D., Sampson, John H., Mitchell, Duane A., Bigner, Darell D.
Publicado em 2009

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy

Por Nair, Smita K, De Leon, Gabriel, Boczkowski, David, Schmittling, Robert, Xie, Weihua, Archer, Gerald, Sampson, John H, Mitchell, Duane A
Publicado em 2013

EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma

Por Choi, Bryan D., Archer, Gary E., Mitchell, Duane A., Heimberger, Amy B., McLendon, Roger E., Bigner, Darell D., Sampson, John H.
Publicado em 2009

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma

Por Sayour, Elias J., McLendon, Pat, McLendon, Roger, De Leon, Gabriel, Reynolds, Renee, Kresak, Jesse, Sampson, John H., Mitchell, Duane A.
Publicado no Cancer Immunol Immunother (2015)